249 related articles for article (PubMed ID: 32313226)
1. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
2. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
3. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
[TBL] [Abstract][Full Text] [Related]
4. YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation.
Skouloudaki K; Walz G
PLoS One; 2012; 7(4):e35735. PubMed ID: 22558212
[TBL] [Abstract][Full Text] [Related]
5. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X
J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241
[TBL] [Abstract][Full Text] [Related]
8. Angiomotin-like 1 plays a tumor-promoting role in glioma by enhancing the activation of YAP1 signaling.
Xu G; Seng Z; Zhang M; Qu J
Environ Toxicol; 2021 Dec; 36(12):2500-2511. PubMed ID: 34480788
[TBL] [Abstract][Full Text] [Related]
9. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Yao Y; Wang Y; Li L; Xiang X; Li J; Chen J; Liu Z; Huang S; Xiong J; Deng J
J Cell Mol Med; 2019 Dec; 23(12):8076-8089. PubMed ID: 31559693
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
12. Angiomotin-like proteins associate with and negatively regulate YAP1.
Wang W; Huang J; Chen J
J Biol Chem; 2011 Feb; 286(6):4364-70. PubMed ID: 21187284
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression.
Wu Y; Shen L; Liang X; Li S; Ma L; Zheng L; Li T; Yu H; Chan H; Chen C; Yu J; Jia J
Cancer Med; 2019 Jul; 8(8):3965-3980. PubMed ID: 31145543
[TBL] [Abstract][Full Text] [Related]
14. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.
Lim B; Park JL; Kim HJ; Park YK; Kim JH; Sohn HA; Noh SM; Song KS; Kim WH; Kim YS; Kim SY
Carcinogenesis; 2014 May; 35(5):1020-7. PubMed ID: 24325916
[TBL] [Abstract][Full Text] [Related]
15. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
[TBL] [Abstract][Full Text] [Related]
16. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
17. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
18. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma.
Liu J; Zhao X; Wang K; Zhang X; Yu Y; Lv Y; Zhang S; Zhang L; Guo Y; Li Y; Yang A; Zhang R; Li J
Cell Death Dis; 2019 Jun; 10(6):452. PubMed ID: 31175271
[TBL] [Abstract][Full Text] [Related]
19. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.
Yu S; Zhang Y; Li Q; Zhang Z; Zhao G; Xu J
Cell Death Dis; 2019 Dec; 10(12):949. PubMed ID: 31827075
[TBL] [Abstract][Full Text] [Related]
20. H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling.
Chen B; Liu X; Yu P; Xie F; Kwan JSH; Chan WN; Fang C; Zhang J; Cheung AHK; Chow C; Leung GWM; Leung KT; Shi S; Zhang B; Wang S; Xu D; Fu K; Wong CC; Wu WKK; Chan MWY; Tang PMK; Tsang CM; Lo KW; Tse GMK; Yu J; To KF; Kang W
Clin Transl Med; 2023 Nov; 13(11):e1481. PubMed ID: 37983931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]